Sanofi Faces Scrutiny For Potential Multiple Sclerosis Blockbuster At Critical EMA Meeting

 
• By Francesca Bruce
  
Sanofi was this week scheduled to defend its MS drug at an EMA oral explanation meeting. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EMA

More from Agency Leadership